Cargando…
In Silico Discovery and Subsequent Characterization of Potent 4R-Tauopathy Positron Emission Tomography Radiotracers
[Image: see text] A chemical fingerprint search identified Z3777013540 (1-(5-(6-fluoro-1H-indol-2-yl)pyrimidin-2-yl)piperidin-4-ol; 1) as a potential 4R-tau binding ligand. Binding assays in post-mortem Alzheimer’s disease (AD), progressive supranuclear palsy (PSP), and corticobasal degeneration (CB...
Autores principales: | , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
American Chemical Society
2023
|
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10424182/ https://www.ncbi.nlm.nih.gov/pubmed/37487189 http://dx.doi.org/10.1021/acs.jmedchem.3c00775 |
_version_ | 1785089619462717440 |
---|---|
author | Graham, Thomas J. A. Lindberg, Anton Tong, Junchao Stehouwer, Jeffrey S. Vasdev, Neil Mach, Robert H. Mathis, Chester A. |
author_facet | Graham, Thomas J. A. Lindberg, Anton Tong, Junchao Stehouwer, Jeffrey S. Vasdev, Neil Mach, Robert H. Mathis, Chester A. |
author_sort | Graham, Thomas J. A. |
collection | PubMed |
description | [Image: see text] A chemical fingerprint search identified Z3777013540 (1-(5-(6-fluoro-1H-indol-2-yl)pyrimidin-2-yl)piperidin-4-ol; 1) as a potential 4R-tau binding ligand. Binding assays in post-mortem Alzheimer’s disease (AD), progressive supranuclear palsy (PSP), and corticobasal degeneration (CBD) brain with [(3)H]1 provided K(D) (nM) values in AD = 4.0, PSP = 5.1, and CBD = 4.5. In vivo positron emission tomography (PET) imaging in rats with [(18)F]1 demonstrated good brain penetration and rapid clearance from normal brain tissues. A subsequent molecular similarity search using 1 as the query revealed an additional promising compound, Z4169252340 (4-(5-(6-fluoro-1H-indol-2-yl)pyrimidin-2-yl)morpholine; 21). Binding assays with [(3)H]21 provided K(D) (nM) values in AD = 1.2, PSP = 1.6, and CBD = 1.7 and lower affinities for binding aggregated α-synuclein and amyloid-beta. PET imaging in rats with [(18)F]21 demonstrated a higher brain penetration than [(18)F]1 and rapid clearance from normal brain tissues. We anticipate that 1 and 21 will be useful for the identification of other potent novel 4R-tau radiotracers. |
format | Online Article Text |
id | pubmed-10424182 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2023 |
publisher | American Chemical Society |
record_format | MEDLINE/PubMed |
spelling | pubmed-104241822023-08-15 In Silico Discovery and Subsequent Characterization of Potent 4R-Tauopathy Positron Emission Tomography Radiotracers Graham, Thomas J. A. Lindberg, Anton Tong, Junchao Stehouwer, Jeffrey S. Vasdev, Neil Mach, Robert H. Mathis, Chester A. J Med Chem [Image: see text] A chemical fingerprint search identified Z3777013540 (1-(5-(6-fluoro-1H-indol-2-yl)pyrimidin-2-yl)piperidin-4-ol; 1) as a potential 4R-tau binding ligand. Binding assays in post-mortem Alzheimer’s disease (AD), progressive supranuclear palsy (PSP), and corticobasal degeneration (CBD) brain with [(3)H]1 provided K(D) (nM) values in AD = 4.0, PSP = 5.1, and CBD = 4.5. In vivo positron emission tomography (PET) imaging in rats with [(18)F]1 demonstrated good brain penetration and rapid clearance from normal brain tissues. A subsequent molecular similarity search using 1 as the query revealed an additional promising compound, Z4169252340 (4-(5-(6-fluoro-1H-indol-2-yl)pyrimidin-2-yl)morpholine; 21). Binding assays with [(3)H]21 provided K(D) (nM) values in AD = 1.2, PSP = 1.6, and CBD = 1.7 and lower affinities for binding aggregated α-synuclein and amyloid-beta. PET imaging in rats with [(18)F]21 demonstrated a higher brain penetration than [(18)F]1 and rapid clearance from normal brain tissues. We anticipate that 1 and 21 will be useful for the identification of other potent novel 4R-tau radiotracers. American Chemical Society 2023-07-24 /pmc/articles/PMC10424182/ /pubmed/37487189 http://dx.doi.org/10.1021/acs.jmedchem.3c00775 Text en © 2023 The Authors. Published by American Chemical Society https://creativecommons.org/licenses/by-nc-nd/4.0/Permits non-commercial access and re-use, provided that author attribution and integrity are maintained; but does not permit creation of adaptations or other derivative works (https://creativecommons.org/licenses/by-nc-nd/4.0/). |
spellingShingle | Graham, Thomas J. A. Lindberg, Anton Tong, Junchao Stehouwer, Jeffrey S. Vasdev, Neil Mach, Robert H. Mathis, Chester A. In Silico Discovery and Subsequent Characterization of Potent 4R-Tauopathy Positron Emission Tomography Radiotracers |
title | In
Silico Discovery and Subsequent
Characterization of Potent 4R-Tauopathy Positron Emission Tomography
Radiotracers |
title_full | In
Silico Discovery and Subsequent
Characterization of Potent 4R-Tauopathy Positron Emission Tomography
Radiotracers |
title_fullStr | In
Silico Discovery and Subsequent
Characterization of Potent 4R-Tauopathy Positron Emission Tomography
Radiotracers |
title_full_unstemmed | In
Silico Discovery and Subsequent
Characterization of Potent 4R-Tauopathy Positron Emission Tomography
Radiotracers |
title_short | In
Silico Discovery and Subsequent
Characterization of Potent 4R-Tauopathy Positron Emission Tomography
Radiotracers |
title_sort | in
silico discovery and subsequent
characterization of potent 4r-tauopathy positron emission tomography
radiotracers |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10424182/ https://www.ncbi.nlm.nih.gov/pubmed/37487189 http://dx.doi.org/10.1021/acs.jmedchem.3c00775 |
work_keys_str_mv | AT grahamthomasja insilicodiscoveryandsubsequentcharacterizationofpotent4rtauopathypositronemissiontomographyradiotracers AT lindberganton insilicodiscoveryandsubsequentcharacterizationofpotent4rtauopathypositronemissiontomographyradiotracers AT tongjunchao insilicodiscoveryandsubsequentcharacterizationofpotent4rtauopathypositronemissiontomographyradiotracers AT stehouwerjeffreys insilicodiscoveryandsubsequentcharacterizationofpotent4rtauopathypositronemissiontomographyradiotracers AT vasdevneil insilicodiscoveryandsubsequentcharacterizationofpotent4rtauopathypositronemissiontomographyradiotracers AT machroberth insilicodiscoveryandsubsequentcharacterizationofpotent4rtauopathypositronemissiontomographyradiotracers AT mathischestera insilicodiscoveryandsubsequentcharacterizationofpotent4rtauopathypositronemissiontomographyradiotracers |